We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ultra-Fast Cycling for Multiplexed Cellular Fluorescence Imaging

By LabMedica International staff writers
Posted on 07 Apr 2020
In the treatment of tumors, microenvironment plays an important role. It often contains immune cells that are so changed that they promote tumor growth. Until now, analyses of these dynamic changes with conventional biopsies and tissue sections could take days to weeks, or not occur at all prior to treatment.

One alternative method is fine needle aspiration, in which only a few thousand cells are taken from different parts of a tumor and its surroundings. This method has few risks and is faster because it does not require embedding or sectioning. However, to obtain a representative estimate of the immune cell populations in the tumor's microenvironment, many different stains must be carried out.

Image: Ultra-fast Cycling for Multiplexed Cellular Fluorescence Imaging (Photo courtesy of Massachusetts General Hospital Research Institute).
Image: Ultra-fast Cycling for Multiplexed Cellular Fluorescence Imaging (Photo courtesy of Massachusetts General Hospital Research Institute).

A team of scientist led by those at the Massachusetts General Hospital Research Institute and the Harvard Medical School (Boston, MA, USA) have developed an ultrafast, highly efficient, and gentle cyclic method for multiplexed protein profiling of individual cells, which allows for numerous different staining. Instead of splitting off the dye or bleaching it, the fluorescence of the stain is simply "switched off" with a black hole quencher. Black hole quenchers absorb the energy of a fluorescence dye over the entire visible spectrum and convert it to heat as soon as they get near enough. This switches off the glow of the dye.

The method uses a connector that contains a trans-cyclooctene group, a fluorescent dye that is attached to antibodies that specifically recognize the characteristic marker molecules of the cells. If the target marker is in a given sample, the antibody binds to it and the fluorescence can be detected. Then the quencher carrying a tetrazine group is added. Using this tetrazine group and the trans-cyclooctene, the quencher can simply be attached by being "clicked" on as though with a snap (hence the term click chemistry for this type of reaction). The quencher is thus site-specifically and very quickly and efficiently brought near to the dye, immediately quenching its fluorescence.

The rapidity of this click reaction is remarkable, running orders of magnitude faster than expected. The reason for this may be the strong interaction between the fluorescence dye and the quencher. The next fluorescent antibody can be applied immediately after the fluorescence quenching. The scientists were able to stain twelve different marker molecules in a sample within one hour. This makes it possible to rapidly characterize the immune cell populations in tumors to select the most suit able treatments.

The authors concluded that this novel method allowed multi‐cycle staining and immune cell profiling within an hour, leveraging the accelerated kinetics to open new diagnostic possibilities for rapid cellular analyses. The study was published in an early online version in the January 2020 edition of the journal Angewandte Chemie International Edition.

Related Links:
Massachusetts General Hospital Research Institute


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Latest Immunology News

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients